Literature DB >> 8914593

Effect of isolation protocol on eosinophil function: Percoll gradients versus immunomagnetic beads.

J B Sedgwick1, Y Shikama, M Nagata, K Brener, W W Busse.   

Abstract

Studies of in vitro eosinophil function are dependent on efficient and reliable methods of cell isolation. Protocols using Percoll or metrizamide density gradients have been of limited use in isolating peripheral blood eosinophils in sufficient numbers and purity from subjects with normal or only slightly elevated eosinophil counts, thereby restricting comparative studies to preparations from hypereosinophilic subjects. Recently, a method utilizing negative selection by anti-CD16 coated magnetic beads has greatly improved eosinophil isolation by dramatically increased yields and purity. However, little is known as to the differential effect of various isolation methods on the functional activity of eosinophils. In this study, eosinophils were isolated by either discontinuous multiple density Percoll gradients or anti-CD16-coated magnetic beads: several functional activities were then compared using cells obtained by the two methods of isolation. Compared with Percoll isolated eosinophils, anti-CD16 bead separated eosinophils had significantly increased baseline and stimulated LTC4 production, spontaneous O2- generation, and expression of specific cell surface markers. No significant difference was observed in the cells' in vitro survival and adhesion. Such differences may be due to the isolation of eosinophils of all densities by anti-CD16 beads, or the effect of neutrophils interacting with the beads to release eosinophil agonists or primers. Alternatively, the Percoll gradient method with the eosinophils' exposure to dextran and Ficoll-Hypaque may affect subsequent cell function. Therefore, comparison of eosinophil function between cells isolated by different protocols must be considered before concluding which is the true measure of in vivo cell function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914593     DOI: 10.1016/0022-1759(96)00139-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4(+) and CD8(+) T cells with a T-helper 1 profile.

Authors:  Ana P Garro; Laura S Chiapello; José L Baronetti; Diana T Masih
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

2.  Isolation of human eosinophils.

Authors:  K G Lim; P F Weller
Journal:  Curr Protoc Immunol       Date:  2001-05

3.  Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection.

Authors:  Ana P Garro; Laura S Chiapello; Jose L Baronetti; Diana T Masih
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

4.  Mouse splenocyte enrichment strategies via negative selection for broadened single-cell transcriptomics.

Authors:  Thomas T Schulze; Andrew J Neville; Ryan C Chapman; Paul H Davis
Journal:  STAR Protoc       Date:  2022-05-17

5.  Isolation of human eosinophils: microbead method has no impact on IL-5 sustained viability.

Authors:  Caroline M Percopo; Kimberly D Dyer; Kristin E Killoran; Helene F Rosenberg
Journal:  Exp Dermatol       Date:  2009-09-15       Impact factor: 3.960

6.  Purification of functional eosinophils from human bone marrow.

Authors:  Tina W Wong; Diane F Jelinek
Journal:  J Immunol Methods       Date:  2012-10-22       Impact factor: 2.303

7.  Isolation of human eosinophils.

Authors:  Praveen Akuthota; Revital Shamri; Peter F Weller
Journal:  Curr Protoc Immunol       Date:  2012-08

Review 8.  Eosinophil Activation Status in Separate Compartments and Association with Asthma.

Authors:  Mats W Johansson
Journal:  Front Med (Lausanne)       Date:  2017-06-12

9.  Integrins are Mechanosensors That Modulate Human Eosinophil Activation.

Authors:  Mustafa Ahmadzai; Mike Small; Roma Sehmi; Gail Gauvreau; Luke J Janssen
Journal:  Front Immunol       Date:  2015-10-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.